financetom
Technology
financetom
/
Technology
/
Breaking Down Oracle: 14 Analysts Share Their Views
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Breaking Down Oracle: 14 Analysts Share Their Views
Mar 5, 2025 10:30 AM

In the last three months, 14 analysts have published ratings on Oracle , offering a diverse range of perspectives from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 6 6 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 0 2 0 0 0
3M Ago 1 4 6 0 0

The 12-month price targets, analyzed by analysts, offer insights with an average target of $195.57, a high estimate of $220.00, and a low estimate of $150.00. This upward trend is apparent, with the current average reflecting a 9.35% increase from the previous average price target of $178.85.

Deciphering Analyst Ratings: An In-Depth Analysis

In examining recent analyst actions, we gain insights into how financial experts perceive Oracle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
John Difucci Guggenheim Maintains Buy $220.00 $220.00
Patrick Walravens JMP Securities Maintains Market Outperform $205.00 $205.00
Thomas Blakey Cantor Fitzgerald Announces Overweight $214.00 -
Tyler Radke Citigroup Raises Neutral $194.00 $157.00
Karl Keirstead UBS Raises Buy $210.00 $200.00
Brad Reback Stifel Raises Hold $175.00 $155.00
Patrick Walravens JMP Securities Maintains Market Outperform $205.00 $205.00
Keith Bachman BMO Capital Raises Market Perform $205.00 $173.00
Gil Luria DA Davidson Raises Neutral $150.00 $140.00
Rishi Jaluria RBC Capital Maintains Sector Perform $165.00 $165.00
Siti Panigrahi Mizuho Raises Outperform $210.00 $185.00
Kirk Materne Evercore ISI Group Raises Outperform $200.00 $190.00
Keith Weiss Morgan Stanley Raises Equal-Weight $175.00 $145.00
Brent Bracelin Piper Sandler Raises Overweight $210.00 $185.00

Key Insights:

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Oracle. This information provides a snapshot of how analysts perceive the current state of the company.

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Oracle compared to the broader market.

Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Oracle's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Oracle's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Oracle analyst ratings.

All You Need to Know About Oracle

Oracle provides enterprise applications and infrastructure offerings around the world through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used for running online transaction processing and data warehousing workloads. Besides database systems, Oracle also sells enterprise resource planning, or ERP, customer relationship management, or CRM, and human capital management, or HCM, applications. Today, Oracle has more than 159,000 full-time employees in over 170 countries.

Financial Milestones: Oracle's Journey

Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.

Revenue Growth: Oracle's remarkable performance in 3 months is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 8.64%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 22.41%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Oracle's ROE stands out, surpassing industry averages. With an impressive ROE of 25.66%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Oracle's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.15% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: With a high debt-to-equity ratio of 6.45, Oracle faces challenges in effectively managing its debt levels, indicating potential financial strain.

The Core of Analyst Ratings: What Every Investor Should Know

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Price Over Earnings Overview: PTC
Price Over Earnings Overview: PTC
Jan 30, 2025
In the current session, the stock is trading at $190.23, after a 0.61% increase. Over the past month, PTC Inc. ( PTC ) stock increased by 5.53%, and in the past year, by 8.06%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be...
Intel forecasts first-quarter revenue below estimates
Intel forecasts first-quarter revenue below estimates
Jan 30, 2025
Jan 30 (Reuters) - Intel's ( INTC ) first-quarter revenue forecast on Thursday missed analyst estimates, as the chipmaker grapples with tepid demand for traditional data center chips and declining share in the key personal computer market. As the chipmaker undergoes a historic transition and attempts to emerge from one of its bleakest periods, it has also struggled to cash...
DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation
DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation
Jan 30, 2025
DeepSeek’s breakthrough AI model has kept the AI industry buzzing these past two weeks, sending stocks of big names in tech plummeting. However, there is one sector that leverages AI but is not susceptible to its volatility, and that is healthcare tech. Health care tech benefits from advancements in AI while sidestepping the megacap tech names that often dominate portfolios....
Lawmakers urge Trump to consider new curbs on Nvidia chips used by China's Deepseek
Lawmakers urge Trump to consider new curbs on Nvidia chips used by China's Deepseek
Jan 30, 2025
WASHINGTON, Jan 30 (Reuters) - Two U.S. Congress members are calling on President Donald Trump's administration to consider restricting the export of artificial intelligence chips made by Nvidia ( NVDA ), alleging Chinese AI firm DeepSeek has relied on them. Republican John Moolenaar and Democrat Raja Krishnamoorthi, who lead the House Select Committee on China, asked for the move as...
Copyright 2023-2025 - www.financetom.com All Rights Reserved